Citigroup Investing Cash Flow increased by 74.9% to -$12.39B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 87.5%, from -$98.98B to -$12.39B. Over 2 years (FY 2021 to FY 2024), Investing Cash Flow shows an upward trend with a -12.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$37.18B | -$33.96B | $0.00 | -$38.82B | -$21.99B | -$36.21B | -$3.07B | $45.79B | -$12.71B | -$38.47B | $14.84B | $12.27B | $51.39B | $7.75B | -$98.98B | -$10.00B | -$49.33B | -$12.39B |
| QoQ Change | — | +8.7% | +100.0% | — | +43.3% | -64.6% | +91.5% | >999% | -127.8% | -202.6% | +138.6% | -17.3% | +318.8% | -84.9% | <-999% | +89.9% | -393.2% | +74.9% |
| YoY Change | — | — | — | — | +40.8% | — | +92.1% | +308.2% | — | -6.2% | +583.0% | -73.2% | +504.3% | +120.1% | -766.8% | -119.5% | -736.6% | +87.5% |